These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15170895)

  • 1. Intratumoral methotrexate kinetics in a patient with intracranial anaplastic ependymoma.
    Geis T; Peters O; Friedrich M; Dränert E; Wolff JE
    Pediatr Blood Cancer; 2004 Jul; 43(1):78-80. PubMed ID: 15170895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial methotrexate kinetics in primary breast cancer lesions.
    Müller M; Brunner M; Schmid R; Mader RM; Bockenheimer J; Steger GG; Steiner B; Eichler HG; Blöchl-Daum B
    Cancer Res; 1998 Jul; 58(14):2982-5. PubMed ID: 9679959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methotrexate for intraocular lymphoma.
    Batchelor TT; Kolak G; Ciordia R; Foster CS; Henson JW
    Clin Cancer Res; 2003 Feb; 9(2):711-5. PubMed ID: 12576439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.
    Devineni D; Klein-Szanto A; Gallo JM
    Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of tritiated methotrexate in a transplantable mouse glioma.
    Tator CH
    Cancer Res; 1976 Sep; 36(9 pt.1):3058-66. PubMed ID: 975073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92.
    Timmermann B; Kortmann RD; Kühl J; Rutkowski S; Dieckmann K; Meisner C; Bamberg M
    Radiother Oncol; 2005 Dec; 77(3):278-85. PubMed ID: 16300848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fever as a risk factor causing delayed elimination of methotrexate in pediatric patients receiving high doses of cancer chemotherapy.
    Kagawa Y; Mukohara R; Hori H; Kawasaki H; Komada Y; Kojima M
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):34-8. PubMed ID: 15024606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged accumulation of high-dose methotrexate in a case with large liver cysts.
    Kawakami M; Omori H; Yamagami T; Soma T
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):619-22. PubMed ID: 19319534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL).
    Weigel R; Senn P; Weis J; Krauss JK
    Clin Neurol Neurosurg; 2004 Mar; 106(2):82-7. PubMed ID: 15003295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of malignant effusions on methotrexate disposition.
    Li J; Gwilt P
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):373-82. PubMed ID: 12439595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.
    DeGregorio M; Wilbur B; King O; Wallenberg J; Prewitt S; Phillips J; Wilbur J
    Cancer Treat Rep; 1986 Dec; 70(12):1437-8. PubMed ID: 3791256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy.
    Cole PD; Zebala JA; Alcaraz MJ; Smith AK; Tan J; Kamen BA
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):826-34. PubMed ID: 16170572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapy.
    Tator CH; Wassenaar W
    J Neurosurg; 1977 Feb; 46(2):165-74. PubMed ID: 833633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
    Fernández Megía MJ; Alós Almiñana M; Esquer Borrás J
    Farm Hosp; 2004; 28(6):433-9. PubMed ID: 15628946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implanted system for intraventricular drug infusion in central nervous system tumors.
    Dakhil S; Ensminger W; Kindt G; Niederhuber J; Chandler W; Greenberg H; Wheeler R
    Cancer Treat Rep; 1981; 65(5-6):401-11. PubMed ID: 6263475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system.
    Mendu DR; Chou PP; Soldin SJ
    Ther Drug Monit; 2007 Oct; 29(5):632-7. PubMed ID: 17898655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
    Yuan SH; Ge WH; Huo J; Wang XH
    Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
    Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
    Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
    Morikawa N; Mori T; Kawashima H; Takeyama M; Abe T; Kobayashi H
    Biol Pharm Bull; 2001 Apr; 24(4):436-8. PubMed ID: 11305611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats.
    Dukic S; Heurtaux T; Kaltenbach ML; Hoizey G; Lallemand A; Gourdier B; Vistelle R
    Pharm Res; 1999 Aug; 16(8):1219-25. PubMed ID: 10468023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.